Top Crypto Trends- DOGE and BTC and Thumzup Media Corporation's (Nasdaq: $TZUP) @thumz_up Impact on Investors

 

Top Crypto Trends- DOGE and BTC and Thumzup Media Corporation's (Nasdaq: $TZUP) @thumz_up Impact on Investors

 

Other Stocks Mentioned: (Nasdaq: $DOMH), (Nasdaq: $ABTC), (Nasdaq: $HUT), (NASDAQ: $CIFR) (NASDAQ: $RIOT)

 

 

 

Investorideas.com, a global news source and expert investing resource covering crypto stocks issues a news snapshot of trending news in the sector featuring Thumzup Media Corporation (Nasdaq:TZUP), pioneering a new era of digital marketing and financial innovation.

 

Looking at what was trending last week, CoinDesk journalist Siamak Masnavi reported, “DOGE's surge in attention came from two developments, Santiment said. Rex-Osprey is preparing to launch what would be the first U.S.-listed Dogecoin exchange-traded fund, while Trump-backed Thumzup (Nasdaq:TZUP) announced an expansion of its mining operations with the purchase of 3,500 rigs.”

 

Thumzup Media Corporation (Nasdaq:TZUP) recently issued a shareholder letter outlining its strategic transformation into a leader in cryptocurrency mining, supported by a pending acquisition of DogeHash Technologies, Inc. ("DogeHash"), a dedicated Dogecoin mining company.

 

Paid News Dissemination of behalf of TZUP

Read this news, featuring TZUP in full at https://www.investorideas.com/news/2025/cryptocurrency/09081top-crypto-trends-doge-btc-thumzup-tzup-investors.asp

 

From the news:

We invested an initial $1 million in Bitcoin (BTC) in January 2025. The positive investor response validated our vision and rewarded our BTC Allocation Strategy.

 

Following this positive shareholder reaction, we intensified our strategy, authorizing further investments in select cryptocurrencies. In late January, we invested another $1 million in Bitcoin. This was followed by a $6.5 million raise at $6 per share in June 2025 from strategic investors. This transaction not only fortified our cap table but also forged a pivotal relationship with Dominari Securities (a principal subsidiary of Dominari Holdings Inc. Nasdaq:DOMH), a powerhouse investment bank with deep expertise and networks in the cryptocurrency ecosystem.

 

It also brought in key strategic investors to the Company's shareholder base. In early August 2025 we closed a $50 million all common stock offering through Dominari Securities at $10 per share.  This influx of healthy capital further strengthened our balance sheet and positioned us for a transformative launch into the cryptocurrency space.

 

On August 19^th, we announced the execution of definitive agreements that are subject to shareholder approval to acquire a premier Dogecoin mining operation currently mining with 2,500 state-of-the-art mining rigs, with another 1,000 best in class miners ordered, that should be delivered later this year. With substantial high-margin revenues, this transaction places Thumzup on an accelerated, high-confidence trajectory to significant shareholder value creation, and could likely surpass the potential of our original digital advertising platform with reduced need for outside capital.

 

With capital from our recent offering, we expect to further expand this fleet, with the goal of materially increasing our revenue run-rate into 2026 and beyond. According to Bitmain, as an example, Antminer L9s (which are similar to the miners Dogehash utilizes but are not identical) have a hash rate of 16 GH/s (Gigahash) consuming 3,360W of power (Crypto Miner). As an illustrative example, Bitmain's mining calculator estimates 3,500 of these miners could generate high-margin annual revenues of the following at these Dogecoin prices (Bitmain):

 

$0.22/DOGE: $22.70 million (current market price)

$0.30/DOGE: $30.96 million

$0.40/DOGE: $41.28 million

$0.50/DOGE: $51.60 million

$1.00/DOGE: $103.19 million

 

Actual results may vary, and this estimate is as of September 2, 2025. This pending acquisition marks the Company's entry into the rapidly growing $10.5 billion cryptocurrency mining market, which is projected to reach $22.6 billion by 2035, which is an 8.9% CAGR, according to Business Research Insights. Importantly, it should diversify our revenue streams while positioning us as one of the few publicly-traded, utility-scale Dogecoin miners.

 

Cryptocurrency Mining: Seizing a Massive Opportunity

Cryptocurrency mining presents what could be one of the greatest opportunities for value creation in the industry. In December 2024, BIT Mining Limited, a publicly traded cryptocurrency miner, reported that its Dogecoin mining operations were nearly three times more profitable than Bitcoin mining alone.

 

Dogecoin, with a market capitalization exceeding $36 billion and daily trading volume of $4 billion as of August 13, 2025 (CoinMarketCap), is one of the most widely held cryptocurrencies and is now held in more than 5 million wallets (Bitcoinist).

 

In January 2025, President Donald Trump signed an executive order strengthening America's leadership in digital financial technology, established a strategic Bitcoin reserve, and advanced the Genius Act, all of which have accelerated institutional and global confidence in cryptocurrency.

 

Further, there are now more than 40 publicly traded cryptocurrency mining operators with the top three reaching multi-billion-dollar valuations. MARA Holdings is the leader with a current $5.6 billion market capitalization, CleanSpark with a $4.5 billion market capitalization, and Riot Platforms with a $3 billion market capitalization.

 

In recent months, more than 100 public companies have adopted, "Digital Asset Treasury Strategies," putting billions of dollars of cryptocurrency on their balance sheets. Several of these companies are holding cryptocurrency, and we believe that positioning Thumzup at the nexus of both mining and holding various cryptocurrencies is our pathway to potentially becoming the next multi-billion-dollar play in this space.

 

Companies such as Bitmine Immersion Technologies have gone from relative obscurity to multi-billion-dollar market capitalizations in a matter of weeks. We believe Thumzup is uniquely positioned to capture similar momentum, combining the scale of our planned Dogecoin mining operations with digital asset treasury strategies.

 

To further support our rapid growth, we expanded our partnership with Coinbase Prime in May 2025, establishing a Bitcoin-backed credit facility and gaining access to institutional-grade trading, financing, and custody services. This strengthens our ability to scale efficiently while pursuing a diversified digital asset treasury strategy. In addition to Bitcoin, our Board has authorized holding Dogecoin (DOGE), Litecoin (LTC), Solana (SOL), Ripple (XRP), Ether (ETH), and USD Coin (USDC).

 

We recently created a crypto advisory board and appointed Alex Hoffman as its first member. Hoffman currently serves as head of ecosystem at DogeOS, the Dogecoin app layer, where he leads ecosystem development, partnerships and growth strategy. His expertise focuses on helping holders and companies put their Dogecoin to work through lending, staking and other applications that generate yield and expand utility. We expect to add other members to the Advisory Board in the near future.

 

The stock made multiple headline news on the update including Benzinga- Thumzup To Expand Into Dogecoin Mining With DogeHash Acquisition Plans and Investing.com - Thumzup shares rise as company pivots to Dogecoin mining.

 

CoinDesk also reported, ”According to Santiment, BTC dominated conversation as users debated its role as “digital gold,” its long-term investment appeal and the significance of growing government and institutional involvement. The firm noted that discussion also emphasized self-custody and the use of nodes as a way to secure the network.”

 

Another Trump-related crypto stock went public last week, announcing the market debut of American Bitcoin Corp. (Nasdaq: ABTC), a Bitcoin accumulation platform focused on building America's Bitcoin infrastructure backbone, trading on the Nasdaq under the ticker symbol "ABTC" following the completion of its stock-for-stock merger with Gryphon Digital Mining, Inc. American Bitcoin delivers institutional-grade exposure to Bitcoin through a differentiated business model that integrates scaled Bitcoin mining operations with disciplined accumulation strategies.

 

From the news:

"Today, American Bitcoin becomes a premier public vehicle for investors seeking scalable, singular exposure to the defining asset class of our time," said Eric Trump, Co-founder and Chief Strategy Officer of American Bitcoin. "Our Nasdaq debut marks a historic milestone in bringing Bitcoin into the core of U.S. capital markets and advancing our mission to make America the undisputed leader of the global Bitcoin economy."

 

"American Bitcoin embodies the values that define American strength: freedom, transparency, and independence," said Donald Trump Jr., stockholder of American Bitcoin. "With our Nasdaq listing, we are elevating this mission onto the global stage, giving investors a vehicle we believe will strengthen the U.S. financial system and help build a more resilient national economy."

 

"With the backing of the public markets, we believe American Bitcoin is now positioned to set the standard in Bitcoin accumulation," said Asher Genoot, Executive Chairman of American Bitcoin and CEO of Hut 8 Corp. (Nasdaq:HUT) (TSX:HUT), which launched American Bitcoin in 2025 as a majority-owned subsidiary. "By combining Bitcoin mining, opportunistic market purchases, and the backing of Hut 8's energy and digital infrastructure, we have created a vehicle designed to drive rapid, efficient Bitcoin-per-share growth."  

 

Last week Cipher Mining Inc. (NASDAQ:CIFR) released its unaudited production and operations update for August 2025. The stock hit a 52 week high as Bitcoin trended.

 

From the news:

Key Highlights

 

Key Metrics    August 2025

BTC Mined1   241

BTC Sold       42

BTC Held       1,414

Deployed Mining Rigs         115,000

Month End Operating Hashrate (EH/s)     23.0

Month End Fleet Efficiency (J/TH)  17.3

 

1 Includes August power sales estimates (based on current meter data and nodal prices) equivalent to ~5 bitcoin (using month-end bitcoin price of $107,631) and ~20 BTC mined at JV data centers representing Cipher’s ownership

 

Management Commentary for August

Black Pearl Phase I continued to scale production this month, accounting for approximately 39% of Cipher’s total bitcoin mined in August. With all rig deliveries on schedule, the Company maintains expectations that Black Pearl Phase I will reach ~10 EH/s by the end of the third quarter, bringing Cipher’s total self-mining hashrate to ~23.5 EH/s.

 

Bitcoin Production and Operations Updates for August 2025

Cipher produced ~2411 BTC in August. As part of its regular treasury management process, Cipher sold ~42 BTC in August, ending the month with a balance of ~1,414 BTC.

 

On September 3^rd, well-known crypto stock, Riot Platforms, Inc. (NASDAQ: RIOT), a Bitcoin-driven industry leader in the development of large-scale data centers for high performance compute and bitcoin mining applications, announced unaudited production and operations updates for August 2025.

 

“Riot produced 477 bitcoin in the month of August,” said Jason Les, CEO of Riot. “This production is an all-time high for Riot in the month of August and represents a 48% increase relative to August 2024. We were able to achieve strong production results while still realizing a low all-in cost of power of 2.6c/kWh for the month, which is a strong demonstration of the benefits of Riot’s unique power strategy and the capabilities of our power management team.”

 

Looking at the trends, a recent article said, “Crypto sentiment can shift in hours, and the next breakout often starts with a spike in curiosity.”

 

Research more crypto stocks at Investorideas.com

https://www.investorideas.com/Bitcoin-Cryptocurrency/Stocks_List.asp#

 

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

Disclaimer/Disclosure: This article featuring TZUP is paid for content and news dissemination. This is not investment opinion. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ More disclaime: https://www.investorideas.com/About/Disclaimer.asp

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.

800 665 0411

 

 

 

Crypto Mining Stocks and Dogecoin’s Edge to Bitcoin’s Powerhouse Revolution

 

Crypto Mining Stocks and Dogecoin’s Edge to Bitcoin’s Powerhouse Revolution

 

Stocks Mentioned- (Nasdaq: $TZUP) @thumz_up , (Nasdaq: $DOMH), (NASDAQ: $MARA), (Nasdaq: $CLSK), (Nasdaq: $WULF)

 

  

Investorideas.com, a global news source and expert investing resource covering crypto stocks issues a news snapshot of some of the well-known crypto mining stocks, featuring Thumzup Media Corporation (Nasdaq:TZUP), pioneering a new era of digital marketing and financial innovation.

 

According to Cypto-economy.com, “Cryptocurrencies are still very much at the forefront of innovation, and mining is one of the solid foundations of blockchain networks. In 2025, Bitcoin (BTC), Litecoin (LTC), and Dogecoin (DOGE) remain three of the most talked about coins in the mining industry. While their underlying technology is different, each presents its unique possibilities for miners and cloud mining enthusiasts.”

 

Experts agree Dogecoin mining is typically more accessible and potentially more profitable for small-scale miners compared to Bitcoin. Its Scrypt algorithm is less resource-intensive, the network difficulty is lower, and it supports Auxiliary Proof-of-Work (Auxpow), enabling simultaneous mining with Litecoin. This allows mining with standard hardware like home PCs or smartphones, while Bitcoin mining demands costly, specialized ASIC miners.

 

Yesterday, Thumzup Media Corporation (Nasdaq:TZUP) issued a shareholder letter outlining its strategic transformation into a leader in cryptocurrency mining, supported by a pending acquisition of DogeHash Technologies, Inc. ("DogeHash"), a dedicated Dogecoin mining company.

 

Paid News Dissemination of behalf of TZUP

 

Read this news, featuring TZUP in full at https://www.investorideas.com/news/2025/cryptocurrency/09051crypto-mining-stocks-dogecoin-vs-bitcoin-revolution.asp

 

From the news:

We invested an initial $1 million in Bitcoin (BTC) in January 2025. The positive investor response validated our vision and rewarded our BTC Allocation Strategy.

 

Following this positive shareholder reaction, we intensified our strategy, authorizing further investments in select cryptocurrencies. In late January, we invested another $1 million in Bitcoin. This was followed by a $6.5 million raise at $6 per share in June 2025 from strategic investors. This transaction not only fortified our cap table but also forged a pivotal relationship with Dominari Securities (a principal subsidiary of Dominari Holdings Inc. Nasdaq:DOMH), a powerhouse investment bank with deep expertise and networks in the cryptocurrency ecosystem.

 

It also brought in key strategic investors to the Company's shareholder base. In early August 2025 we closed a $50 million all common stock offering through Dominari Securities at $10 per share.  This influx of healthy capital further strengthened our balance sheet and positioned us for a transformative launch into the cryptocurrency space.

 

On August 19^th, we announced the execution of definitive agreements that are subject to shareholder approval to acquire a premier Dogecoin mining operation currently mining with 2,500 state-of-the-art mining rigs, with another 1,000 best in class miners ordered, that should be delivered later this year. With substantial high-margin revenues, this transaction places Thumzup on an accelerated, high-confidence trajectory to significant shareholder value creation, and could likely surpass the potential of our original digital advertising platform with reduced need for outside capital.

 

With capital from our recent offering, we expect to further expand this fleet, with the goal of materially increasing our revenue run-rate into 2026 and beyond. According to Bitmain, as an example, Antminer L9s (which are similar to the miners Dogehash utilizes but are not identical) have a hash rate of 16 GH/s (Gigahash) consuming 3,360W of power (Crypto Miner). As an illustrative example, Bitmain's mining calculator estimates 3,500 of these miners could generate high-margin annual revenues of the following at these Dogecoin prices (Bitmain):

 

$0.22/DOGE: $22.70 million (current market price)

$0.30/DOGE: $30.96 million

$0.40/DOGE: $41.28 million

$0.50/DOGE: $51.60 million

$1.00/DOGE: $103.19 million

 

Actual results may vary, and this estimate is as of September 2, 2025. This pending acquisition marks the Company's entry into the rapidly growing $10.5 billion cryptocurrency mining market, which is projected to reach $22.6 billion by 2035, which is an 8.9% CAGR, according to Business Research Insights. Importantly, it should diversify our revenue streams while positioning us as one of the few publicly-traded, utility-scale Dogecoin miners.

 

Cryptocurrency Mining: Seizing a Massive Opportunity

Cryptocurrency mining presents what could be one of the greatest opportunities for value creation in the industry. In December 2024, BIT Mining Limited, a publicly traded cryptocurrency miner, reported that its Dogecoin mining operations were nearly three times more profitable than Bitcoin mining alone.

 

Dogecoin, with a market capitalization exceeding $36 billion and daily trading volume of $4 billion as of August 13, 2025 (CoinMarketCap), is one of the most widely held cryptocurrencies and is now held in more than 5 million wallets (Bitcoinist).

 

In January 2025, President Donald Trump signed an executive order strengthening America's leadership in digital financial technology, established a strategic Bitcoin reserve, and advanced the Genius Act, all of which have accelerated institutional and global confidence in cryptocurrency.

 

Further, there are now more than 40 publicly traded cryptocurrency mining operators with the top three reaching multi-billion-dollar valuations. MARA Holdings is the leader with a current $5.6 billion market capitalization, CleanSpark with a $4.5 billion market capitalization, and Riot Platforms with a $3 billion market capitalization.

 

In recent months, more than 100 public companies have adopted, "Digital Asset Treasury Strategies," putting billions of dollars of cryptocurrency on their balance sheets. Several of these companies are holding cryptocurrency, and we believe that positioning Thumzup at the nexus of both mining and holding various cryptocurrencies is our pathway to potentially becoming the next multi-billion-dollar play in this space.

 

Companies such as Bitmine Immersion Technologies have gone from relative obscurity to multi-billion-dollar market capitalizations in a matter of weeks. We believe Thumzup is uniquely positioned to capture similar momentum, combining the scale of our planned Dogecoin mining operations with digital asset treasury strategies.

 

To further support our rapid growth, we expanded our partnership with Coinbase Prime in May 2025, establishing a Bitcoin-backed credit facility and gaining access to institutional-grade trading, financing, and custody services. This strengthens our ability to scale efficiently while pursuing a diversified digital asset treasury strategy. In addition to Bitcoin, our Board has authorized holding Dogecoin (DOGE), Litecoin (LTC), Solana (SOL), Ripple (XRP), Ether (ETH), and USD Coin (USDC).

 

We recently created a crypto advisory board and appointed Alex Hoffman as its first member. Hoffman currently serves as head of ecosystem at DogeOS, the Dogecoin app layer, where he leads ecosystem development, partnerships and growth strategy. His expertise focuses on helping holders and companies put their Dogecoin to work through lending, staking and other applications that generate yield and expand utility. We expect to add other members to the Advisory Board in the near future.

 

The stock closed up at $5.57,+0.28,+5.29% on the news.

 

Yesterday, MARA Holdings, Inc. (NASDAQ:MARA), a leading digital energy and infrastructure company, published unaudited bitcoin production updates for August 2025.

 

From the news:

Management Commentary

"Similar to last month, we produced 208 blocks in August as global hashrate increased 6% month-over-month to an average of 949 EH/s," said Fred Thiel, MARA's chairman and CEO. "Given the decline in bitcoin price during the month, we took the opportunity to strategically add to our treasury and currently hold over 52,000 BTC.

 

"Our energized hashrate grew 1% over the prior month, and all containers and miners at our Texas wind farm are on-site and connected. We are on track to be fully operational at the site in the fourth quarter.

 

"We recently announced the signing of an investment agreement allowing MARA to acquire a 64% stake in Exaion, a subsidiary of EDF, one of the world's largest low-carbon energy producers, with the option to increase our ownership up to 75% by 2027. The transaction is expected to close in or around Q4 2025, subject to customary closing requirements and regulatory approval. Upon closing, this joint venture would formalize the convergence of our technology stack and AI in developing new solutions that can lower the cost of processing and secure the edge infrastructure that will support the growing AI economy. Furthermore, we established our European headquarters in Paris and welcomed European business leaders to accelerate our international growth strategy. Together, these announcements reinforce MARA’s role in advancing energy partnerships dedicated to stabilizing power grids while capturing and repurposing unused energy."

 

CleanSpark, Inc. (Nasdaq:CLSK), America's Bitcoin Miner, just announced its unaudited Bitcoin mining and operations update for the month ended August 31, 2025.

 

"I am proud of the work our operations and technology teams accomplished in August as they successfully managed through the summer heat, raising our average operating hashrate month over month," said Taylor Monnig, Chief Technology Officer. "We will continue optimizing our sites ahead of cooler weather and the upcoming miner deployments later this year."

 

"While August was a month of leadership transition, CleanSpark remained unwavering in its focus on operational performance and in continuing to grow our bitcoin treasury to build long-term value for all stakeholders," said Matt Schultz, CEO and Chairman.

 

"Over the past calendar year, we've doubled our hashrate and built a bitcoin treasury of nearly 13,000. We are now focused on maximizing our contracted power through mining and exploring other verticals. We have a proven track record of deliberate, strategic discipline, and I am excited to enter our next phase of growth without ever losing sight of what got us here."

 

Evidencing the ongoing investor interest in the crypto miners, TeraWulf Inc. (Nasdaq:WULF) a leading owner and operator of vertically integrated, predominantly zero-carbon digital infrastructure, recently announced that the initial purchasers of 1.00% Convertible Senior Notes due 2031 (the “Convertible Notes”) have fully exercised their option to purchase an additional $150 million aggregate principal amount of notes. The option was exercised on August 21, 2025, and the purchase was completed on August 22, 2025. Including the greenshoe, the total principal amount of Convertible Notes sold in the offering was $1.0 billion.

 

According to CoinDesk.com, “The total market cap of the 13 US-listed bitcoin (BTC) miners the bank tracks also hit a record high in August, with high-performance computing (HPC) execution driving the gains.”

 

The digital revolution continues…

Research more crypto stocks at Investorideas.com

https://www.investorideas.com/Bitcoin-Cryptocurrency/Stocks_List.asp#

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

Disclaimer/Disclosure: This article featuring TZUP is paid for content and news dissemination. This is not investment opinion. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ More disclaime: https://www.investorideas.com/About/Disclaimer.asp

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.

800 665 0411

 

 

 

Medtech Stocks – How a company’s IP portfolio Creates Market Leaders

 

Medtech Stocks – How a company’s IP portfolio Creates Market Leaders

 

Stocks Mentioned: (Nasdaq: $AEMD), (NASDAQ: $IINN), (NASDAQ: $AMIX), (NYSE: $PHG)

 

 

September 4, 2025- Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking at innovation and the importance of IP in medtech,, featuring Aethlon Medical, Inc. (Nasdaq:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

 

Medical Device Online reported in July, “The global medical device market is estimated to be currently about $680 billion and is projected to grow to over a trillion dollars within 10 years at a compound annual growth rate of 6%. As the medical device industry continues to expand, intellectual property (IP) considerations — especially those concerning patents — are critical for medical device innovators and manufacturers. For companies, developing IP is essential for securing funding, negotiating partnerships, and positioning themselves as leaders in the industry. For investors, a company’s IP portfolio signifies its ability to maintain market exclusivity and defend against competition.”

 

Aethlon Medical, Inc. (Nasdaq:AEMD) with its unique medical device, Hemopurifier®, is building an impressive list of patents issued and pending. It just announced that US Patent No. 12,409,260 ("the “260 Patent") directed to treatment of Long COVID will issue on September 9, 2025, and Unitary European Patent 4136453 (the “453 Patent)” directed to the treatment of COVID-19-associated coagulopathy (“CAC”) was issued July 9, 2025.

 

Paid News Dissemination of behalf of AEMD.

 

Read this news featuring AEMD in full at: https://www.investorideas.com/CO/AEMD/news/2025/09041medtech-stocks-ip-portfolio-market-leaders.asp

 

From the news:

The 260 Patent is intended to protect the use of the Hemopurifier® in the United States to treat patients that have a reduced COVID-19 viral load but exhibit Long COVID symptoms for more than 12 weeks post infection. The 260 Patent additionally protects the treatment of patients experiencing Long COVID symptoms by the removal of circulating COVID-19 spike protein.

 

The 453 Patent is intended to protect the use of the Hemopurifier® for the treatment of patients that lack circulating COVID-19 viral particles but exhibit COVID-19-associated CAC.

 

The 260 Patent was granted an additional 385 days of patent term due to patent term adjustment and will expire in 2042. The 453 Patent will expire in 2041.

 

"We believe securing these patents expands and strengthens our intellectual property portfolio in areas of significant unmet medical need,” said James Frakes, CEO and CFO of Aethlon. “While the Hemopurifier® remains in the research and development stage relating to Long COVID, these protections position us well as we continue advancing potential future applications. Our goal is to build a strong foundation of innovation that could one day translate into meaningful treatment options for patients."

 

The Aethlon Hemopurifier® is an investigational medical device designed to remove enveloped viruses, fragments of viruses, and tumor-derived extracellular vesicles (EVs) from circulation. It is used extra-corporeally with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich surfaces found on EVs and viral proteins. EVs released by solid tumors are believed to play a role in metastasis and the resistance to immunotherapies and chemotherapy. Removal of enveloped viruses, fragments of viruses, and extracellular vesicles has been demonstrated in both in vitro studies and in human patients.

 

The Hemopurifier® holds a US Food and Drug Breakthrough Device Designation for:

The treatment of individuals with advanced or metastatic cancer unresponsive to or intolerant of standard-of-care therapy; and the treatment of life-threatening viruses not addressed with approved therapies.

 

In addition to this patent news, Aethlon has the following patents issued and multiple patents pending in the US and Internationally:

 

International Patents issued

14 patents covering exosomes and microvesicular particle removal

• Patent protection extending to 2031 in Germany, France, Great Britain and Spain

• Patent protection extending to 2027 in Canada, Switzerland, Italy, Netherlands, Sweden, Hong Kong, Demark and Ireland

• 4 patents covering removal of Covid-19 viral particles and associated exosomes.

• Patent protection extending to 2041 in Unitary Patent member states, Switzerland, Great Britain and Spain

 

Issued Patents In United States:

• 4 patents issued covering extracorporeal removal of microvesicular particles, patent protection until 2029

 

Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN), a pioneer in innovative life-support and diagnostic technologies recently announced it received US Patent approval for low flow rates extracorporeal oxygenation system and methods of use. This patent represents the core technology of the ART500 device, a key asset in the Company’s strategy to penetrate the $20 billion estimated market for advanced respiratory support. This innovation has 16 claims found to be novel.

 

From the news:

The patent provides further protection for the underlying core technology of Inspira’s ART500 system, which is designed to provide extracorporeal oxygenation at low flow rates while maintaining patient safety and treatment efficiency. This capability targets a large, underserved patient population that requires respiratory support but may not be sick enough for traditional, high-flow ECMO systems, significantly expanding the potential market for Inspira's technology. This approval strengthens Inspira’s intellectual property portfolio and reinforces the Company’s technological leadership in the field of advanced extracorporeal life support.

 

Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, stated: "This patent has profound business implications for Inspira and for our ability to dominate a market with a potential size of $20 billion. We are creating a new therapeutic category for conscious, spontaneously breathing patients. Protecting our intellectual property is a critical pillar of our growth strategy, and this patent approval provides us with a distinct competitive advantage. While our ART100 system is already generating commercial momentum, this move fortifies our future and gives us the clear runway needed to translate our technological leadership into long-term value for our shareholders, and a new standard of care for patients worldwide."

 

The newly received patent provides protection at least until the year 2043, covering key claims related to the ART500’s functionality, design, and clinical applications. Inspira is pursuing additional patents in major jurisdictions worldwide to expand its intellectual property coverage.

 

In late August, Autonomix Medical, Inc. (NASDAQ:AMIX), a medical device company dedicated to advancing precision nerve-targeted treatments announced that European Patent Office (EPO) has granted Patent No. 3,697,298 (the ‘298 patent), titled, “Medical Device with Circuitry for Capturing and Processing Physiological Signals.” The newly issued ‘298 patent relates to use of its proprietary technology to collect and process sensing data for real-time physiological monitoring with broad application use that includes coronary artery/vagal nerve mapping, arterial/renal mapping, bladder/lower urinary tract applications, robotic prosthetics and implants, and central nervous system monitoring for neurotherapy.

 

Earlier this year, Royal Philips (NYSE:PHG) announced that in 2024 it was the leading applicant in the field of medical technology at the European Patent Office (EPO), filing 594 Medtech patent applications. This achievement underscores the company's ongoing dedication to transforming healthcare delivery by integrating informatics and AI to improve workflows, enhance the quality of care, and lower costs of care per patient.

 

From the news:

AI-enabled cardiovascular ultrasound platform

 

The innovations by Philips, which can boast 134 years of innovation history with its research and development programs around the globe, improved the health and well-being of nearly 2 billion people in 2024, keeping it on track towards its target of 2.5 billion lives improved in 2030.

 

Roy Jakobs, CEO of Royal Philips said: "For more than 130 years, Philips has been at the forefront of innovations improving people’s lives. The 2024 European patent rankings show how we continue to innovate in the hospital and the home – helping to deliver better care for more people. To continue driving greater impact, we have shifted our innovation closer to customers. We want to help healthcare professionals improve patient care and empower people everywhere to take care of their health and well-being.”

As informatics and AI increasingly create value for healthcare, both at the hospital as well as at home, approximately half of the company’s R&D investments are focused on these technologies. 

 

 Some of the informatics and AI-powered innovations that Philips launched in 2024 include:

 

·        The new Azurion image-guided therapy system with advanced informatics to enhance minimally invasive diagnosis and treatment of stroke and other neurovascular patients.

 

·        FDA-cleared AI tools integrated into the EPIQ CVx and Affiniti CVx ultrasound system to advance cardiovascular imaging and increase automation and productivity, reinforcing Philips’ #1 global position in cardiovascular ultrasound.

 

·        The new Philips Spectral CT 7500 RT, enabling personalized radiation therapy planning to deliver better care to more cancer patients.

 

·        FDA approval for the LumiGuide Navigation Wire, which uses fiber optic technology to reduce radiation for both patients and physicians during minimally invasive surgery.

 

In total, Philips contributed 1,231 European patent applications across various domains, the most of any Dutch company and continuing the company’s legacy as one of the top applicants since the EPO started publishing the rankings in 2004.

 

Based on market projections from leading analysts, the medical device market is set for significant expansion, fueled by technological advancements and growing healthcare needs.

 

Aethlon Medical, Inc. (Nasdaq:AEMD) is advancing its Hemopurifier® blood purification device globally with a growing patent portfolio to strengthen its long-term competitive advantage in the sector.

Research biotech and medical device/ tech stocks at Investorideas.com

https://www.investorideas.com/BIS/

 

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

 

Disclaimer/Disclosure: This news article featuring AEMD is a paid for news release on Investorideas.com. AEMD is an annual featured showcase stock at Investorideas.com  This is not investment opinion. Our site does not make recommendations for purchases or sale of stocks, services or products.  This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services and prices on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 

 

Medical Tech Stock Aethlon Medical (Nasdaq: $AEMD) Announces Issuance of Hemopurifier Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

 

Medical Tech Stock Aethlon Medical (Nasdaq: $AEMD) Announces Issuance of Hemopurifier Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

 

 

SAN DIEGO, CA, September 3, 2025 – (Investorideas.com Newswire) – Breaking Medical tech stock news- Aethlon Medical, Inc. (Nasdaq: AEMD) announced that U.S. Patent No. 12,409,260 ("the “260 Patent") directed to treatment of Long COVID will issue on September 9, 2025, and Unitary European Patent 4136453 (the “453 Patent)” directed to the treatment of COVID-19-associated coagulopathy (“CAC”) issued July 9, 2025.

 

The 260 Patent is intended to protect the use of the Hemopurifier® in the United States to treat patients that have a reduced COVID-19 viral load but exhibit Long COVID symptoms for more than 12 weeks post infection.  The 260 Patent additionally protects the treatment of patients experiencing Long COVID symptoms by the removal of circulating COVID-19 spike protein.

 

The 453 Patent is intended to protect the use of the Hemopurifier® for the treatment of patients that lack circulating COVID-19 viral particles but exhibit COVID-19-associated CAC.

The 260 Patent was granted an additional 385 days of patent term due to patent term adjustment and will expire in 2042. The 453 Patent will expire in 2041.

 

Paid News Dissemination of behalf of AEMD.

 

Read this news, featuring AEMD in full at: https://www.investorideas.com/CO/AEMD/news/2025/09031aethlon-medical-hemopurifier-long-covid-cac-patents-aemd.asp

 

"We believe securing these patents expands and strengthens our intellectual property portfolio in areas of significant unmet medical need,” said James Frakes, CEO and CFO of Aethlon. “While the Hemopurifier® remains in the research and development stage relating to Long COVID, these protections position us well as we continue advancing potential future applications. Our goal is to build a strong foundation of innovation that could one day translate into meaningful treatment options for patients."

 

About the Hemopurifier^®

The Aethlon Hemopurifier® is an investigational medical device designed to remove enveloped viruses, fragments of viruses, and tumor-derived extracellular vesicles (EVs) from circulation. It is used extracorporeally with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich surfaces found on EVs and viral proteins. EVs released by solid tumors are believed to play a role in metastasis and the resistance to immunotherapies and chemotherapy. Removal of enveloped viruses, fragments of viruses, and extracellular vesicles has been demonstrated in both in vitro studies and in human patients.

 

The Hemopurifier® holds a U.S. Food and Drug Breakthrough Device Designation for:

The treatment of individuals with advanced or metastatic cancer unresponsive to or intolerant of standard-of-care therapy; and the treatment of life-threatening viruses not addressed with approved therapies.

 

About Aethlon Medical, Inc.

Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical-stage medical device company headquartered in San Diego, California. Aethlon is advancing the Hemopurifier®, to address unmet needs in oncology and infectious disease, using a novel platform designed to selectively remove circulation pathogenic targets from biologic fluids.

 

For more information,visit www.AethlonMedical.com and follow the Company on LinkedIn.

 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," "potentially" or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such differences include, without limitation, the Company's ability to raise additional capital on terms favorable to the Company, or at all; the Company's ability to successfully complete development of the Hemopurifier; the Company's ability to successfully demonstrate the utility and safety of the Hemopurifier in cancer and infectious diseases, COVID-19 and in the transplant setting; the Company's ability to achieve and realize the anticipated benefits from operational and financial milestones; the Company's ability to obtain approval from the Ethics Committee of its third location in Australia, including on the timeline expected by the Company; the Company's ability to enroll additional patients in its oncology clinical trial in Australia, including on the timeline expected by the Company; the Company's ability to manage and successfully complete its clinical trials; the Company's ability to successfully manufacture the Hemopurifier in sufficient quantities for its clinical trials; unforeseen changes in regulatory requirements; the Company's collaborative research with UCSF Long Covid Clinic; and the Company's ability to further research potential applications of the Hemopurifier in other EV-associated diseases, the ability of the Company to maintain its current Patents and other potential risks. The foregoing list of risks and uncertainties is illustrative but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.

 

Company Contact:
Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

 

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com

 

Aethlon Medical is a showcase company at Investorideas.com

Visit: https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Aethlon Medical, Inc. (AEMD) is a paid featured medical tech stock on Investor ideas More disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

 

Get more biotech and medical tech news, articles, podcasts and stock directories